{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:59:25Z","timestamp":1784033965402,"version":"3.55.0"},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T00:00:00Z","timestamp":1530144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/jcpt.12727","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T05:53:37Z","timestamp":1530251617000},"page":"906-909","source":"Crossref","is-referenced-by-count":7,"title":["Concomitant use of sorafenib with ombitasvir\/paritaprevir\/ritonavir and dasabuvir: Effectiveness and safety in clinical practice"],"prefix":"10.1155","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-8928","authenticated-orcid":false,"given":"J. L.","family":"Revuelta-Herrero","sequence":"first","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gim\u00e9nez-Manzorro","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Matilla-Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Gastroenterology Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Herranz-Alonso","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanjurjo-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,28]]},"reference":[{"key":"10.1111\/jcpt.12727-BIB0001|jcpt12727-cit-0001","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"issue":"suppl 7","key":"10.1111\/jcpt.12727-BIB0002|jcpt12727-cit-0002","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/annonc\/mds225","article-title":"Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Verslype","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1111\/jcpt.12727-BIB0003|jcpt12727-cit-0003","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12727-BIB0004|jcpt12727-cit-0004","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","article-title":"ABT-450\/r-Ombitasvir and Dasabuvir with or without Ribavirin for HCV","volume":"370","author":"Ferenci","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12727-BIB0005|jcpt12727-cit-0005","unstructured":"Liverpool HEP Interactions http:\/\/www.hep-druginteractions.org"},{"key":"10.1111\/jcpt.12727-BIB0006|jcpt12727-cit-0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1111\/jcpt.12727-BIB0007|jcpt12727-cit-0007","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1111\/jcpt.12727-BIB0008|jcpt12727-cit-0008","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2014.03.030","article-title":"Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib","volume":"61","author":"Reig","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12727-BIB0009|jcpt12727-cit-0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5604\/16652681.1231585","article-title":"The impact of early dermatologic events in the survival of patients with hepatocellular carcinoma treated with sorafenib","volume":"16","author":"Branco","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1111\/jcpt.12727-BIB0010|jcpt12727-cit-0010","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1111\/jcpt.12727-BIB0011|jcpt12727-cit-0011","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12727-BIB0012|jcpt12727-cit-0012","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2016.05.045","article-title":"Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: data from three ANRS cohorts","volume":"65","author":"ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts)","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12727-BIB0013|jcpt12727-cit-0013","unstructured":"European Medicines Agency European Public Assessment Reports: Nexavar http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000690\/WC500027704.pdf"},{"key":"10.1111\/jcpt.12727-BIB0014|jcpt12727-cit-0014","unstructured":"European Medicines Agency European Public Assessment Reports: Viekirax http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003839\/WC500183997.pdf"},{"key":"10.1111\/jcpt.12727-BIB0015|jcpt12727-cit-0015","unstructured":"European Medicines Agency European Public Assessment Reports: Exviera http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/003837\/WC500182233.pdf"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12727","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12727\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:49Z","timestamp":1671818629000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12727","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,28]]}}}